COVID-19 933 Views Pfizer and BioNTech to evaluate COVID-19 booster and new vaccine variants Malin Otmani March 1, 2021 Pfizer and BioNTech have begun …
Acquisition 1264 Views Oasmia acquires rights for Cantrixil Malin Otmani March 1, 2021 Oasmia Pharmaceutical has signed an …
Clinical Trials 1026 Views First child vaccinated in Scandinavian Biopharma’s Phase IIb Gambia trial Malin Otmani March 1, 2021 The first child has been …
Biotech Business 2154 Views Oncopeptides receives FDA approval Malin Otmani March 1, 2021 FDA has approved Oncopeptides’ PEPAXTO …
Clinical Trials 1104 Views XNK Therapeutics enters joint Phase II study Malin Otmani February 26, 2021 XNK Therapeutics is entering into …
Collaboration 1518 Views Novo Nordisk and the University of Toronto announce joint investment Malin Otmani February 24, 2021 The DKK 200 million investment …
Acquisition 2189 Views Xbrane divests Primm Pharma Malin Otmani February 24, 2021 Xbrane Biopharma has entered into …
Agreement 2199 Views GPX Medical signs agreement with BTC Health Australia Malin Otmani February 24, 2021 The agreement gives BTC Health, …
Pharma Business 1783 Views Pre Diagnostics completes proof of concept study Malin Otmani February 23, 2021 Pre Diagnostics has announced that …
Biotech Business 1713 Views BioInvent carries out a directed share issue of USD 116 million Malin Otmani February 23, 2021 The company plans to in …
COVID-19 1394 Views The SciLifeLab program on COVID-19 vaccine effects is launched Malin Otmani February 23, 2021 In December 2020, SciLifeLab and …
Pharma Business 836 Views Voluntary withdrawal of Imfinzi indication in advanced bladder cancer Malin Otmani February 23, 2021 AstraZeneca has announced the voluntary …
COVID-19 1040 Views Capitainer’s system employed in COVID-19 study in the US Malin Otmani February 22, 2021 The company’s qDBS dried blood …
Clinical Trials 1121 Views Diaprost announces promising results Malin Otmani February 22, 2021 Diaprost has announced a publication …
Pharma Business 883 Views Immunicum receives orphan drug designation Malin Otmani February 22, 2021 The European Medicines Agency Committee …
Clinical Trials 1811 Views First patient treated in Ultimovacs TENDU study Malin Otmani February 18, 2021 Ultimovacs has announced the treatment …